Clinical Trials

New Study Links Glyphosate to Neuroinflammation and Alzheimer's Risks
Research & Development New Study Links Glyphosate to Neuroinflammation and Alzheimer's Risks

The impact of glyphosate exposure on brain health has been a growing concern, and a new study has brought this issue to the forefront. The research highlights the potential link between the widely used herbicide and lasting brain inflammation, which could lead to neurodegenerative diseases such as

Alanis and KBI Partner to Advance Antibody Development for Blood Cancers
Biotech & Bioprocessing Alanis and KBI Partner to Advance Antibody Development for Blood Cancers

In a strategic move to tackle severe blood cancers, Alanis Therapeutics (ATI) has teamed up with KBI Biopharma to enhance the development and manufacturing of ATI's preclinical antibody candidate, ATI-D1. This partnership aims to accelerate the treatment of myelodysplastic syndromes (MDS) and acute

Is the HITS-Bio Technique Revolutionizing Tissue Engineering and Medicine?
Biotech & Bioprocessing Is the HITS-Bio Technique Revolutionizing Tissue Engineering and Medicine?

The field of tissue engineering and regenerative medicine has witnessed a groundbreaking advancement with the development of the High-throughput Integrated Tissue Fabrication System for Bioprinting (HITS-Bio) by researchers from Penn State. This innovative technology promises to transform the

Should Ureteral Stents be Omitted Post-Ureteroscopy for Kidney Stones?
Research & Development Should Ureteral Stents be Omitted Post-Ureteroscopy for Kidney Stones?

Imagine undergoing a medical procedure to remove kidney stones only to face discomfort because of a stent placed to prevent complications. Each year, thousands of patients undergo ureteroscopy to remove kidney stones, and while the procedure is effective, the placement of ureteral stents

New Study Revolutionizes Colorectal Cancer Diagnosis at Telford CDC
Research & Development New Study Revolutionizes Colorectal Cancer Diagnosis at Telford CDC

In a groundbreaking move aiming to reshape the process of diagnosing colorectal cancer, the Community Diagnostic Centre (CDC) in Telford has launched a £1 million research study known as TRIOMIC. This innovative study is designed to significantly shorten the anxiety-inducing waiting period for a

Impact of Menopausal Status on Long-Term Benefits of Tamoxifen in Breast Cancer
Research & Development Impact of Menopausal Status on Long-Term Benefits of Tamoxifen in Breast Cancer

The study conducted by Linda Lindström and her team at Karolinska Institutet delves into the significant role menopausal status plays in the long-term efficacy of tamoxifen, an anti-hormonal treatment for estrogen-sensitive breast cancer. Published in the Journal of the National Cancer Institute

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later